Trial intelligence / Profile preview

Peptide 19 for weight control in adults with obesity

RBR-10zchcdkPhase 2Completed

Sponsor
Fundação do ABC
Start
Mar 2025
Modality
Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of P19 in obesity (3 arms), sponsored by Fundação do ABC. Primary endpoint: Body weight control. Started Mar 2025; status: completed.

02

Drugs

P19
03

Conditions

obesity

Beyond the preview

Go deeper on RBR-10zchcdk.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-10zchcdk.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call